Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
The Global Trade Research Initiative (GTRI) urged India to bolster its local vaccine production and research to enhance ...
India should focus on enhancing local vaccine manufacturing and research for better control over safety, according to GTRI. They also suggest investigating adverse health events post-vaccination to ...
GTRI also suggested the government to launch an investigation to track all adverse health events post-vaccination as this ...
Donald Trump’s electoral victory has shaken the market, mostly in a good way. The S&P 500 gained 5% in the first two days ...
Hosted on MSN1d
Which High-Risk Patients Should Get the RSV Vaccine?All three RSV vaccines -- GSK's Arexvy, Pfizer's Abrysvo, and Moderna's mRESVIA -- are FDA-approved for all adults age 60 and ...
On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...
Hosted on MSN2d
Should Kids Get the COVID-19 Vaccine?Children aged 6 months and older may need one to three doses of either vaccine, depending on their age and vaccination status ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback